Related Experiment Videos
[Pathogenesis of human chronic chagasic myocarditis]
R P Laguens1, P M Cabeza Meckert, C A Vigliano
1División Patología, Fundación Favaloro, Buenos Aires, Argentina. laguens@netverk.com.ar
Medicina
|February 11, 2000
Summary
While autoimmunity was suspected, new evidence suggests parasite components, not just immune responses, drive chronic chagasic myocarditis. Early treatment with trypanocidal drugs may prevent heart disease development.
Area of Science:
- Immunology
- Parasitology
- Cardiology
Background:
- Chronic chagasic myocarditis has long been attributed to autoimmune processes.
- Evidence included molecular mimicry, autoantibodies, and experimental induction of myocarditis.
Observation:
- Human myocarditis infiltrates show diverse cells, including non-autoreactive types, and granulomas.
- Pericarditis association and focal lesions challenge purely autoimmune explanations.
- Early trypanocidal treatment prevents cardiopathy, and parasite components are found at lesion sites.
Findings:
- Autoimmunity alone may not fully explain the chronic, polymorphic nature of chagasic myocarditis.
- Tiny parasite fragments, even below detection limits, appear crucial for inducing extensive inflammation.
Implications:
- Alternative pathogenetic mechanisms beyond autoimmunity are needed.
- Further research should explore how minimal parasite presence triggers persistent myocarditis.